What we did here is look at tissue in 3D and then map the genetic alterations onto that 3D model,” explained Laura Wood, M.D., Ph.D., Associate Professor of Pathology and Oncology at the Johns Hopkins ...

A new drug strategy that regulates the tumor immune microenvironment may transform a tumor that resists immunotherapy into a susceptible one, according to a new study.

Pancreatic cancer develops quietly, with symptoms that may seem insignificant at first glance. This cancer affects the ...

A new study provides more evidence that GLP-1 RAs don’t raise the risk for pancreatic cancer and may in fact offer some protection.

A new drug strategy that regulates the tumor immune microenvironment may transform a tumor that resists immunotherapy into a ...

To determine the type and severity of a cancer, pathologists typically analyze thin slices of a tumor biopsy under a ...

These findings could pave the way for new treatment approaches for cancers driven by RAS mutations. Researchers at the ...

Now a new study, led by UC San Francisco and University of Michigan, has demonstrated that using an artificial intelligence (AI)-powered diagnostic tool helps neurosurgeons identify invisible cancer ...

CODA, the first ever 3D genome profiling technique, was able to make a 3D print of pre-cancerous cells found in a human ...

Ohio State cancer researchers and surgeons are developing and deploying cutting-edge techniques to help patients.